Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Acorda Therapeutics Appoints CFO, CBO | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Acorda Therapeutics Appoints CFO, CBO

Rogers takes on finance and investor relations, Lawrence to lead business operations

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Michael Rogers has been appointed chief financial officer at Acorda Therapeutics, responsible for the company’s finance and investor relations departments. Also, David Lawrence, M.B.A., who previously served as CFO, has been appointed chief of business operations, responsible for technical operations/manufacturing, project management, IT, and facilities management.
 
“I’m delighted to welcome Mike Rogers to Acorda’s senior management team. Mike has a record of success as CFO at both commercial- and development-stage biotechnology companies, as well as a background in investment banking,” said Ron Cohen, M.D., Acorda’s president and chief executive officer. “Mike’s strategic insight and broad experience will help us capitalize on opportunities to expand Acorda’s business and continue to deliver shareholder value.”
 
Mr. Rogers has 22 years of experience in the biopharmaceutical industry. Most recently, he served as executive vice president and chief financial officer of BG Medicine, Inc., where he led the company’s successful IPO in 2011 and assisted in the launch of the company’s first cardiovascular product. Prior to that, Mr. Rogers served as the chief financial officer of Indevus Pharmaceuticals for 10 years until the company’s sale to Endo Pharmaceuticals.
 
Commenting on Mr. Lawrence’s new role as chief of business operations at Acorda, Dr. Cohen said, “Acorda is now at a stage that requires focused leadership of our business operations. Dave has been a key contributor to building the Company over the last 15 years, and we are fortunate to continue to benefit from his capabilities as he expands his role within Acorda.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters